Explore the Agenda

Pre-Conference Day

Monday, July 21

Day One

Tuesday, July 22

Day Two

Wednesday, July 23

7:40 am Check In & Morning Coffee

8:35 am Chair’s Opening Remarks

Jason Zhang
Co-Founder & Chief Executive Officer, Zipcode Bio

8:45 am Biopharma Business Development & Investors Panel: Secure the Financial Future of mRNA Technology Through Trusting Investor Partnerships

Ashoka Madduri
Global Head of Scientific Strategy & Intelligence, mRNA Centre of Excellence, Sanofi
Richard Shen
Managing Director & Interim Chief Executive Officer, Sedgwick Yard & Endotope Biosciences
Ilya Vensky
General Partner, Provisio Ventures
David Kolesky
Principal, MPM BioImpact
Kristin Thompson
Investment Director, Merieux Equity Partners

Download the Full Event Guide to see session details.

Envisioning the Success of mRNA Therapeutics & Vaccines Enabled by Robust Biopharma Partnerships, Licensing & Capital Investment

9:35 am A Look into the RNA Deals & Companies Landscape

Ioana Panait
Technical Lead, Beacon

Download the Full Event Guide to see session details.

9:45 am Advanced Patenting Considerations for mRNA Market Players & New Entrants

Dan Shores
Partner, Rothwell Figg

Download the Full Event Guide to see session details.

10:15 am Morning Break & Networking

Discovery
Discovery

Unravelling Novel Approaches for mRNA-LNP Delivery From Genetic Circuits to Gene Editing in Pre-Clinical Models – Chair

Rachel Groppo
Director, Lead Self-Amplifying RNA Team, Johnson & Johnson

10:45 am RNA-based Genome Engineering by Target-Primed Reverse Transcription

Chauncey Zeng
Associate Director, Tessera Therapeutics

Download the Full Event Guide to see session details.

11:15 am Platinum® Pro Protein Barcoding: Advancing mRNA Drug Development through Multiplexed mRNA Screening with Direct Protein-Level Detection

Joel McDade
Director - Technical Sales, Quantum Si

Download the Full Event Guide to see session details.

11:45 am Preclinical Evaluation of Targeted LNPs (tLNPs) for In Vivo HSC Delivery & Editing

Jimit Raghav
Drug Metabolism & Pharmacokinetics Scientist, Editas Medicine

Download the Full Event Guide to see session details.

Pre-Clinical Development
Clinical
Manufacturing & CMC

12:15 pm Lunch & Networking Break

Discovery
Discovery

Unravelling Novel Approaches for Self-Amplifying RNA Technology Discoveries to Successfully Target the Tumour – Chair

Rachel Groppo
Director, Lead Self-Amplifying RNA Team, Johnson & Johnson

1:15 pm STX-003: Targeting IL-12 Expression to Tumors via mRNA Programmed With Genetic Circuits

Allen Tseng
Senior Principal Scientist – Synthetic Biology, Strand Therapeutics

Download the Full Event Guide to see session details.

1:45 pm Developing Personalized Neoantigen-Based Cancer Vaccines With Self- Amplifying RNA

Nicholas Restifo
Co-Founder & Chief Scientist, Medici Therapeutics

Download the Full Event Guide to see session details.

Pre-Clinical Development
Clinical
Manufacturing & CMC

2:15 pm Afternoon Break & Networking

The Next Wave: Turbocharging Circular RNA Technology Development Towards Effective Vaccine & Therapeutic Applications

2:45 pm Circular RNA: Transforming a Promising Technology Into Cutting-Edge Therapeutics

Edo Kon
Director - Business Development, RiboX Therapeutics

Download the Full Event Guide to see session details.

3:15 pm Scarless Circular mRNA-Based CAR-T Cell Therapy Exhibits Potent Pharmacological Activity

Xian Zeng
Co-Founder & Board Member, Byterna Therapeutics

Download the Full Event Guide to see session details.

3:45 pm CircRNA Platform & the Development of Therapeutics

Chijian Zuo
Vice President, CureMed Biomedical Technology

Download the Full Event Guide to see session details.

4:15 pm Chair’s Closing Remarks

Jason Zhang
Co-Founder & Chief Executive Officer, Zipcode Bio

4:30 pm End of 5th mRNA-Based Therapeutics Summit 2025

View Event Brochure
Pre-Conference Day
Day One